Forum pracy nad projektem wskrzeszenia The Forge

[34nyhv01jck]

Whippany, NJ, United States, 05/29/2007 - New operation bolsters Image Solutions' global support capabilities in response to clients’ growing presence in Asian markets and increased need for speed.

Image Solutions Inc., (ISI), a leader in providing software and services to streamline the drug development lifecycle, announced today the opening of new operations in Tianjin, China. ISI’s expansion in Asia supports the company’s overall commitment to support the globalization of the Life Science Industry. The China operation adds to ISI’s already strong capabilities that exist in Asia through its development center in Korea, testing and support capabilities in India, and in Japan through an alliance with CAC Corporation.
ISI is enhancing its global capabilities to keep pace with its clients’ needs to respond to increased regulatory pressures, the need to reduce overall costs, and the requirement to speed submission timetables. In addition, China has emerged as a preferred location for new markets and lower-cost drug development and manufacturing. Accordingly, ISI is well positioned for the anticipated growth in this region.
The opening of the operation also represents a strategic decision on ISI’s part to blend global resources and services providing unprecedented support for client requirements. For ISI clients, the foremost Life Science organizations in the world, each day of document processing translates into potential lost revenues downstream.
To satisfy this demand for speed and efficiency, ISI can now link multiple offices located in different time zones, and use web-based technology to provide almost 400 man-hours of production time within a single 24 hour day. This capability provides ISI with a unique competitive advantage to meet client timeframes and achieve their goals quickly and cost-effectively.
The focus for the China operation in the short term is CRF Processing. CRFs are the most paper-intensive document process in the Life Science industry with more than five million CRF pages generated each week. CRF processing has been the backbone of ISI services since its inception. To date, ISI has processed more than 50 million pages of CRFs for submission to the FDA. ISI’s CRF services are part of a broad portfolio of business process outsourcing services developed to assist companies in reducing the time and cost associated with compiling electronic submissions, managing data, and preparing scientific documents.
Because of ISI’s ongoing commitment to quality, the operation in China is expected to be ISO certified later in 2007. ISO is a global, centrally managed certification given after rigorous review of standard operating procedures and the assurance that all processes and procedures are centrally controlled. These methods help ISI provide predictable project estimates and stable,[link widoczny dla zalogowanych], high-quality deliverables and demonstrate ISI’s strong commitment to quality by achieving the highest industry standard.
With record performance over the past several years, ISI is aggressively growing operations in the United States, Europe and Asia. This year alone,[link widoczny dla zalogowanych], ISI plans to expand it’s presence in the United States with the opening of operations in two primary biotechnology hotbed regions: Boston, Massachusetts, and San Diego, California. In Europe, ISI will have an increased presence in the United Kingdom.
About Image Solutions,[link widoczny dla zalogowanych], Inc.
Founded in 1992, Image Solutions,[link widoczny dla zalogowanych], Inc. (imagesolutions.com) is a proven market leader in providing submissions solutions,[link widoczny dla zalogowanych], process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI was among the first professional services firm to deliver electronic submissions to the industry and since has delivered nearly 1,000 electronic submissions and 400 eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.
ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognized charitable organizations.